Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS), Masimo (MASI) and REPRO-MED Systems (KRMD)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GeneDx Holdings (WGS – Research Report), Masimo (MASI – Research Report) and REPRO-MED Systems (KRMD – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
GeneDx Holdings (WGS)
In a report released today, Kyle Mikson CFA from Canaccord Genuity maintained a Buy rating on GeneDx Holdings, with a price target of $170.00. The company’s shares closed last Monday at $119.24.
According to TipRanks.com, CFA is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for GeneDx Holdings with a $171.43 average price target, representing a 31.9% upside. In a report released today, TipRanks – DeepSeek also upgraded the stock to Buy with a $150.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Masimo (MASI)
Piper Sandler analyst Jason Bednar reiterated a Buy rating on Masimo today and set a price target of $210.00. The company’s shares closed last Monday at $132.23.
According to TipRanks.com, Bednar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Masimo is a Moderate Buy with an average price target of $188.40, which is a 34.7% upside from current levels. In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $200.00 price target.
REPRO-MED Systems (KRMD)
In a report released today, Caitlin Roberts from Canaccord Genuity reiterated a Buy rating on REPRO-MED Systems, with a price target of $6.00. The company’s shares closed last Monday at $5.89.
According to TipRanks.com, Roberts is a 3-star analyst with an average return of
Currently, the analyst consensus on REPRO-MED Systems is a Strong Buy with an average price target of $6.25, representing a 12.0% upside. In a report issued on December 31, Lake Street also maintained a Buy rating on the stock with a $8.00 price target.
